Just in:
Moomoo Wins “Digital CX Awards 2024” by The Digital Banker // Andertoons by Mark Anderson for Sat, 27 Apr 2024 // Election Commission Of India Degrades Itself To Modi’s Own Commission // VARA Introduces Thai-Inspired Corporate Catering Menu in Seattle, Washington // Winner of Hong Kong’s Flagship Global Elevator Pitch Competition Crowned // UAE’s Deputy Prime Minister Oversees Graduation Ceremony at Dihad Humanitarian College // Liverpool FC continues international growth with first official retail partnership in South Korea // UAE Extends National Day Wishes to Ethiopia // Nobuyoshi Araki’s “Paradise” Presented by Forward Fashion’s Artelli A Hong Kong and Macau Collaborative Tribute to Four Decades of Iconic Photography // Tech Titans Lead Wall Street to Stellar Week // Healthsprings Group Launches New Telemedicine App With Aesthetic Medicine Feature // Forward Fashion’s Artelli Presents: Nobuyoshi Araki’s “Paradise” Starting from April 27th, at K11 MUSEA // Sheikh Saif Bin Zayed Graces DIHAD Humanitarian College Graduation // China Sets Sights on Lunar Riches with Chang’e 6 Launch // “Hello China, Sunshine Hainan” International Media Tour witnessed the evolution of Hainan’s tourism and culture // Abu Dhabi Unveils Designated Grazing Period for 2024 // e& UAE Unveils Strategic Roadmap // Vinhomes, Vietnam largest property developer, unveils a series of new entertainment and shopping destinations // InnoEX cements Hong Kong’s status as an I&T hub // Nano-Care Deutschland AG launches next generation of sustainable PFAS-free oleophobic coatings //

MIMS is the Editorial Contents Provider for Singapore’s NDF Initiative

Media OutReach Logo New
SINGAPORE – Media OutReach – 25 July 2022 – MIMS, the region’s leading healthcare data and medical knowledge provider, is proud to announce that MIMS has successfully collaborated with Singapore’s Ministry of Health (MOH) on the editorial contents for the National Drug Formulary (NDF) website. The NDF is a MOH initiative under the National Pharmacy Strategy and the website is currently live at www.ndf.gov.sg.

The NDF website aims to establish a Singapore-specific, authoritative and national reference to guide evidence-based best practices for medication prescribing, dispensing, administration and monitoring by consolidating local clinical and drug-related information. NDF provides drug and post-marketing information from the Health Sciences Authority (HSA), subsidy information and drug guidance from the Agency for Care Effectiveness (ACE) and, general availability information from all of Singapore’s public healthcare institutions. MIMS, with its team of clinical editors, worked closely with MOH to organize and curate all these information for the NDF website within the stipulated timeframe.

“We at MIMS have been working to empower healthcare communities through our in-house products and services. The NDF website is an important initiative in Singapore’s healthcare landscape and is in line with our vision and mission.,” said Masaki Takahata, Chief Executive Officer of MIMS Group.

ADVERTISEMENT

The Project Lead and Editorial Director at MIMS, Leong Wai Fun said, “We are delighted to have been an editorial partner, contributing to the content curation of NDF and enabling healthcare professionals to select safe and effective medicines for patients in Singapore.”

We look forward to such partnerships in the region and support clinicians in improving patient outcomes.

Hashtag: #MIMS

About MIMS

MIMS Group, a subsidiary of SMS Co. Ltd. (TYO 2175), has been offering diverse expertise for over 50 years in 17 countries and regions in Asia, Oceania and the Middle East with a focus on providing marketing support services to pharmaceutical companies, clinical decision support tools integrated in healthcare institutions as well as services to empower healthcare professionals in their daily operations. MIMS marketing platform services is spread across 10 countries mainly in South East Asia and has over 2.5 million healthcare professionals registered on the our online platform (), with drug directory services, medical communications, as well as media platform businesses.

MIMS has offices in the following countries & regions:

Singapore (Headquarters), Australia, China, Hong Kong SAR (China), Indonesia, India, Ireland, Japan, Korea, Malaysia, Myanmar, New Zealand, Philippines, Taiwan (China), Thailand, United Arab Emirates, and Vietnam.

For more information, please visit

ADVERTISEMENT

ADVERTISEMENT
Just in:
Tech Titans Lead Wall Street to Stellar Week // Winner of Hong Kong’s Flagship Global Elevator Pitch Competition Crowned // Moomoo Wins “Digital CX Awards 2024” by The Digital Banker // Vinhomes, Vietnam largest property developer, unveils a series of new entertainment and shopping destinations // BioMed Technology Among Pioneering Recipients of Investment from CUHK Innovation Limited for Microbiome-based Healthcare Solutions // China Sets Sights on Lunar Riches with Chang’e 6 Launch // Sheikh Saif Bin Zayed Graces DIHAD Humanitarian College Graduation // Election Commission Of India Degrades Itself To Modi’s Own Commission // UAE’s Deputy Prime Minister Oversees Graduation Ceremony at Dihad Humanitarian College // Saudi Arabia on Verge of Sending First Delegate to Miss Universe // Andertoons by Mark Anderson for Sat, 27 Apr 2024 // InnoEX cements Hong Kong’s status as an I&T hub // UAE Extends National Day Wishes to Ethiopia // Crypto Market Poised for Boom as Baby Boomers Embrace Bitcoin ETFs // Abu Dhabi Unveils Designated Grazing Period for 2024 // Grayscale Makes Another Large Bitcoin Transfer to Coinbase Prime // MENA Debt Surge Raises Concerns for Global Economic Stability // Nano-Care Deutschland AG launches next generation of sustainable PFAS-free oleophobic coatings // Healthsprings Group Launches New Telemedicine App With Aesthetic Medicine Feature // Nobuyoshi Araki’s “Paradise” Presented by Forward Fashion’s Artelli A Hong Kong and Macau Collaborative Tribute to Four Decades of Iconic Photography //